Top 10 Medical Stocks For 2018

Despite staggering increases in drug prices, Americans still aren’t living as long as those in other countries. And the worst part is they’re paying more, too…

One out of every four Americans reported that the cost of healthcare is their primary concern right now, according to a January 2017 Monmouth University poll. In fact, anxiety about paying medical bills now outpaces job and unemployment concerns, as well as worries about paying everyday household bills.

And it’s no wonder: In August, prices for medicine, doctor’s appointments, and health insurance rose at rates not seen since 1984.

Drug costs, in particular, are growing by double and triple digits each year. Back in October 2016, The Fiscal Times reported that specialty drug prices grew 18.9% and are projected to increase another 18.7% this year. Additionally, it reported that generic drug prices are expected to increase another 11% this year after already going up 11.3% in 2016.

Top 10 Medical Stocks For 2018: HP Inc.(HPQ)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, technology shares fell 0.11 percent. Meanwhile, top losers in the sector included HP Inc (NYSE: HPQ), down 7 percent, and iRobot Corporation (NASDAQ: IRBT) down 8 percent.

  • [By Alex Cho]

    That being the case, it wouldnt take substantial market share gains for AMD to reverse the multi-year decline in its processor business, as performance/watt is what will drive adoption from key PC makers like Dell, HP Inc (NYSE:HPQ)and Lenovo. AMD hasnt been very competitive in the MPU (microprocessor unit) segment for quite a while, but given the recent node shift to 14nm FinFET over at GlobalFoundries, and mention of new architecture by AMD earlier this year at COMPUTEX Taiwan, I get the impression that performance of Summit Ridge, i.e. Zen will match Skylake and will perhaps come in slightly slower than Kaby Lake.

  • [By Peter Graham]

    Small cap 3D printing stockStratasys, Ltd (NASDAQ: SSYS)reported Q1 earnings before the market opened this morning that met expectations, but shares are falling as much as 10% in premarket trading given the run-up the stock has already had. Stratasys is the largest U.S. manufacturer of 3D printers by revenue whileHP Inc (NYSE: HPQ), which has recently entered the3D printer market,is already number two. Nevertheless,it appears that 3D printing stockshave at least stabilized as the short interest has largely been cleared out.

  • [By Paul Ausick]

    Fourth-quarter 2017 shipments of personal computers (PCs), including desktops and laptops, fell 2% year over year to an estimated 71.56 million units. HP Inc. (NYSE: HPQ) was the volume and market-share leader with worldwide shipments totaling 16.08 million in the quarter and a share of 22.5%. For the full year, worldwide shipments dipped 2.8% to 262.54 million units.

  • [By Teresa Rivas]

    HP Inc. (HPQ) rose to the top of the S&P 500 Wednesday.

    Agence France-Presse/Getty Images

    The shares climbed 48 cents, or 2.7%, to $18.02, compared to the S&P 500, which lost 8.85 points, or 0.38%, to 2344.93.

    HP was helped by data from IDC that showed the firm regained the crown of top PC vendor from rival Levono Group in Q1.

    In addition, Morgan Stanleys Katy Huberty reiterated an Overweight rating on HP and increased her price target to $22 from $19:

    In the past 18 months, HP removed over $1B of excess costs and refocused investment dollars on driving innovation across printing and personal systems. Recent product refreshes, including JetIntelligence laser printers, Sprocket mobile photo printer, and premium and gaming/VR-focused PCs are now driving share gains and a return to top-line growth (total revenue grew 2% and 4% Y/Y in last two fiscal quarters, respectively). By reinventing HP, we believe management is heralding a new era for the company whereby investors can expect greater confidence in top-line stabilization as well as earnings and FCF durability.

    Yesterday, American Airlines(AAL)was the best performing stock in the S&P 500.

Top 10 Medical Stocks For 2018: TRC Companies Inc.(TRR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of TRC Companies, Inc. (NYSE: TRR) got a boost, shooting up 16 percent to $7.53. TRC posted Q4 earnings of $0.20 per share on revenue of $132.3 million.

Top 10 Medical Stocks For 2018: Equinix Inc.(EQIX)

Advisors’ Opinion:

  • [By Lee Jackson]

    This is one of the larger capitalization companies in the data center industry. Equinix Inc. (NASDAQ: EQIX)provides data center services to protect and connect the information assets for the enterprises, financial services companies, and content and network providers primarily in the Americas, Europe, the Middle East, Africa and the Asia-Pacific.

Top 10 Medical Stocks For 2018: Anadarko Petroleum Corporation(APC)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    One of the largest projects is the Saddlehorn Pipeline, which Magellan is building with Plains All American Pipeline (NYSE:PAA) and Anadarko Petroleum (NYSE:APC). Both Plains All American Pipeline and Magellan own 40% of the project, which puts their total investment at $230 million apiece. They expect the project to be fully operational early next year, which is noteworthy given its robust first-year economics. Magellan estimates that it will earn eight times EBITDA on the capital deployed, or roughly $28.8 million in annual EBITDA apiece for Magellan and Plains All American Pipeline on their investment.

  • [By Lisa Levin]

    Shares of Sanchez Energy Corp (NYSE: SN) got a boost, shooting up 28 percent to $11.11. Anadarko Petroleum Corporation (NYSE: APC) announced the sale of Eagleford Shale assets to Sanchez Energy and Blackstone Energy Partners for $2.3 billion.

  • [By WWW.GURUFOCUS.COM]

    For the details of Packer & Co Ltd’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Packer+%26+Co+Ltd

    These are the top 5 holdings of Packer & Co LtdBall Corp (BLL) – 625,005 shares, 7.52% of the total portfolio. Hess Corp (HES) – 2,039,400 shares, 6.78% of the total portfolio. Anadarko Petroleum Corp (APC) – 1,432,600 shares, 6.35% of the total portfolio. Shares added by 14.37%Citigroup Inc (C) – 604,500 shares, 6.34% of the total portfolio. Shares reduced by 11.04%General Electric Co (GE) – 1,118,800 shares, 5.98% o

  • [By Matthew DiLallo]

    While crude prices stumbled into 2016, they found their footing by mid-year and roared back to life, ending the year up about 42%. Those rising prices lifted most oil stocks. However, a handful of large-cap oil stocks rose above the crowd by outperforming crude’s rally. Those top-tier performers wereContinental Resources (NYSE:CLR), Devon Energy (NYSE:DVN), Anadarko Petroleum (NYSE:APC), Pioneer Natural Resources (NYSE:PXD), and Cimarex Energy (NYSE:XEC):

Top 10 Medical Stocks For 2018: Sonoco Products Company(SON)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Deutsche Bank’s Debbie Jones and team contend that Sonoco’s (SON) sale of its plastic-container business to Australia’s Amcor is a sign that M&A is in the offing. They explain why:

    Sonoco announced (9/1) that it is selling its Rigid Plastics Blow Molding operations to Amcor (AMC.AU) for $280M. The transaction price represents a multiple of ~8.0x LTM EBITDA. The business had annual sales of ~$210M and consisted of six production sites in the US and one in Canada. Blow molding operations represented ~10% of Sonocos Consumer Packaging segment sales and EBITDA. The transaction is expected to close in Q4. We expect the proceeds to be used to for M&A focused in flexible packaging, thermoforming and temperature-assured packaging.

    We dont believe Sonoco considered its blow molding operations essential to its growth strategy. This standalone business is also more capital intensive compared to some of its other plastic packaging businesses and SON held a small position in the overall market. Ultimately, the company decided it wants to focus its capital in higher growth platforms. We do not expect the divestment to reduce resin buying scale for Sonoco’s remaining assets given different resin buying. Note that with the divestiture of blow molding and the Canton closures plant (divested in Feb. 2015), this makes the ~$100M reels business the last standalone business in the portfolio, but we do not expect this to be divested in the near-term unless cash is needed for much larger M&A.

    Shares of Sonoco have gained 1.3% to $52.49 at 2:12 p.m. today.

     

Top 10 Medical Stocks For 2018: Utilities Select Sector SPDR ETF (XLU)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    The Dow utility average ended last week at a stabilizing 639.95 after trading as low as 616.19 on Nov. 14. Keep in mind that a “death cross” was confirmed on election day, when the 50-day simple moving average fell below the 200-day simple moving average, indicating that lower prices are likely ahead. The 200-day is now at 666.30. The utility average has returned to my range of key levels of 635.23 and 670.81, which remain magnets for the remainder of 2016. This week’s value level is above the Nov. 14 low at 620.87. Investors seeking the safety of dividends can trade the Utilities Select Sector SPDR Fund (XLU) , which is a basket of 28 utility stocks.

  • [By Craig Jones]

    On CNBC's Options Action, Dan Nathan suggested a bearish options trading idea in Utilities SPDR (ETF) (NYSE: XLU).

    The stock caught his attention, because he noticed a big put options volume last week in the name. He thinks traders should not be in the stock ahead of a possible rate hike.

  • [By ]

    High-yield and traditionally-safe sectors like Utilities, represented by the Utilities Select Sector SPDR (NYSE: XLU), and Consumer Staples, represented by the Consumer Staples Select Sector SPDR (NYSE: XLP), show this relationship with yields.

  • [By Craig Jones]

    Speaking on Bloomberg Markets, Kevin Kelly of Recon Capital Partners suggested that investors with a long position in Utilities SPDR (ETF) (NYSE: XLU) should consider an options strategy that offers protection ahead of the FOMC meeting.

Top 10 Medical Stocks For 2018: American Eagle Outfitters, Inc.(AEO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of American Eagle Outfitters (NYSE: AEO) were down 12 percent to $11.35 after the company posted downbeat quarterly earnings and issued a weak earnings forecast for the current quarter.

  • [By Leo Sun]

    American Eagle Outfitters (NYSE:AEO) trades at 12 times earnings, which is half the industry average of 24 for apparel stores. It pays a forward dividend yield of 3.6%, which is much higher than the S&P 500’s average yield of 2%. That dividend is supported by a payout ratio of 43%, but it hasn’t hiked that payout since 2013.

  • [By Chris Lange]

    American Eagle Outfitters Inc. (NYSE: AEO) released its most recent quarterly results before the markets opened on Thursday. This company joins an increasing number of retailers that saw their earnings fall flat during the fourth quarter. Most recently we saw Dollar Tree and Kroger slip.

Top 10 Medical Stocks For 2018: Principal Financial Group Inc(PFG)

Advisors’ Opinion:

  • [By Ben Levisohn]

    The twenty stocks in Worth’s basket are: Ameriprise Financial (AMP) Bank of America, Banner (BANR), Citigroup, Citizens Financial Group (CFG), East West Bancorp (EWBC), First NBC Bank Holding (FNBC), HFF (HF), KeyCorp(KEY), Legacy Texas Financial Group (LTXB), Lincoln National (LNC), Morgan Stanley, Old National Bancorp (ONB), PacWest Bancorp (PACW), PNC Financial Services Group (PNC), Principal Financial Group (PFG), Stifel Financial (SF), SVB Financial Group (SIVB), TCF Financial (TCB), and Wells Fargo.

Top 10 Medical Stocks For 2018: Seres Therapeutics, Inc.(MCRB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares dropped 70 percent to $10.69 after the company reported interim results from SER-109 Phase 2 ECOSPOR study in multiply recurrent clostridium difficile infection. The study did not achieve primary endpoint.

  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares shot up 35 percent to $12.51. Seres Therapeutics reported initiation of new SER-019 study announced FY16 loss of $2.30 per share on revenue of $21.766 million.

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than

Top 10 Medical Stocks For 2018: Facebook, Inc.(FB)

Advisors’ Opinion:

  • [By Adam Levy]

    Facebook (NASDAQ:FB) is a global phenomenon. Even with 1.86 billion monthly active users as of the end of 2016, the company is still growing its user base at a fairly steady clip in the high teens.

  • [By Ravi Bala]

    Although there is a lot of hype surrounding Virtual Reality (VR) and Facebook’s(NSDQ:FB) Oculus Rift, I have to say that this is not a game changer. In fact, it has been around before. Nintendo was one of the first companies to do this with their virtual boy. However, the outing was considered a colossal failure due to the high price and nascent technology. As times have changed, the capabilities of this technology have gotten better. However, pricing may be the ultimate determinant of who succeeds or wins. Here’s why the Oculus acquisition may turn out to be a bad move and may hurt FB stock.

  • [By Money Morning Staff Reports]

    The former – led by Facebook Inc. (Nasdaq: FB) and Twitter Inc. (NYSE: TWTR), for example – are going to get clobbered, while the broader pullback will give savvy investors in the latter a massive and potentially very profitable opportunity.

Leave a Reply

Your email address will not be published. Required fields are marked *